Safe, low-cost Alzheimer's drug demonstrates efficacy against sickle cell anemia

Memantine, a long-approved and cost-effective drug used to treat Alzheimer’s disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international research group led by the University of Zurich…

Continue Reading

News Source: medicalxpress.com